Radical Transparency or Radical Redundancy? FDA Publishes 200+ Complete Response Letters, Most of Which Are Already Public
The FDA Law Blog
JULY 10, 2025
However, the vast majority of the CRLs posted in the openFDA database are already available in the action packages posted on FDA’s Drugs@FDA database and approved biologics product pages. Greater transparency into our decisions will help align expectations and foster better communication among stakeholders.”
Let's personalize your content